[Asia Economy Reporter Hyunseok Yoo] SomaGen announced on the 26th that it signed two long-term supply contracts for COVID-19 diagnostic services on the 23rd with U.S.-based companies ‘ELLKAY, LLC and CLX Health, LLC’ and ‘Virus Geeks, Inc.’


Most notably, the supply contract with ELLKAY and CLX Health holds great significance as it provides COVID-19 diagnostic services for two years to passengers of the three major U.S. airlines?American Airlines, Delta Air Lines, United Airlines?and their partner airlines, according to the company.


According to the company, as of the 25th, the Ministry of Foreign Affairs reported on its travel safety site that 176 countries require a negative COVID-19 test certificate for visa issuance and entry. With the increasing demand for COVID-19 PCR tests and negative result certificates required 48 to 72 hours before boarding for overseas travel, there is a surge in demand for tests that can provide rapid results.


ELLKAY and CLX Health are meeting this demand by providing COVID-19 tests required by each country according to international protocols to travelers of the three major U.S. airlines and their partner airlines. SomaGen’s ‘Psoma COVID-19 RT Test,’ which has received approval from the U.S. FDA, has been adopted for this purpose.


To provide COVID-19 diagnostic services to the three major U.S. airlines, it is necessary to follow international protocols. The test must be an RT-PCR method approved by the U.S. FDA and must provide rapid and accurate test results within 48 hours. SomaGen meets all these requirements, the company explained.


Additionally, Virus Geeks is a COVID-19 diagnostic testing linkage company located in California, USA. Following this supply contract, SomaGen is expected to provide approximately 10,000 COVID-19 diagnostic tests monthly for two years to businesses and schools within the U.S. The contract with Virus Geeks is the third large-scale supply contract following FTGCare and The Park School, according to the company. SomaGen plans to provide both its ‘Psoma COVID-19 RT Test’ and the saliva sample collection method SalivaDirect™ COVID-19 diagnostic service concurrently to Virus Geeks.



Ryan Kim, CEO of SomaGen, stated, "Many businesses and schools in the U.S. operated remotely through work-from-home and online classes, but with the recent supply of COVID-19 vaccines, normal operations have resumed, increasing the demand for regular large-scale diagnostic testing before and after returning to workplaces and schools. SomaGen is preparing to expand its diagnostic business, including COVID-19 testing, in response to this demand and will actively respond to the continuously surging requests for diagnostic services."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing